{
    "symbol": "KARD",
    "slug": "kard",
    "display_name": "KARD",
    "category": "stocks",
    "region": "US",
    "description": null,
    "url": "https://finscans.com/asset/kard",
    "lang": "en",
    "as_of": "2026-06-01T09:57:19+00:00",
    "stats_30d": {
        "total_signals": 1,
        "bullish": 0,
        "bearish": 0,
        "neutral": 1,
        "explicit": 1,
        "inferred": 0,
        "avg_impact": 4,
        "avg_confidence": 70,
        "last_signal_at": "2026-05-26 23:58:19",
        "article_count": 1
    },
    "top_catalysts": [
        {
            "text": "IPO filing to fund cardiovascular disease treatment",
            "count": 1
        },
        {
            "text": "Potential listing on a major exchange",
            "count": 1
        }
    ],
    "top_risk_factors": [
        {
            "text": "IPO market volatility",
            "count": 1
        },
        {
            "text": "Clinical trial failure risk",
            "count": 1
        }
    ],
    "recent_signals": [
        {
            "signal_at": "2026-05-26 23:58:19",
            "sentiment": "Neutral",
            "impact_score": 4,
            "confidence_score": 70,
            "mention_type": "explicit",
            "timeframe": "short-term",
            "region": "US",
            "reasoning": "Kardigan filed for an IPO to fund cardiovascular disease treatments, a move that could provide capital for clinical trials and pipeline expansion. The IPO filing itself is a critical step toward public listing, often creating short-term speculative interest in the stock once it debuts. However, without disclosed pricing, immediate impact is muted.",
            "article": {
                "title": "Kardigan Files IPO to Fund Cardiovascular Disease Therapies",
                "url": "https://finscans.com/news/kardigan-files-ipo-to-fund-cardiovascular-disease-therapies"
            }
        }
    ]
}